In November 2025, somewhere between Marrakech and the At­las Mountains, an Austrian pro­grammer spent an hour wiring together two pieces of software that would, within weeks, fun­damentally alter the ...

Ubisoft has said its long-awaited Splinter Cell remake remains in development despite layoffs at the studio working on the project.

Ubisoft's cost-cutting continues with significant losses at the studio behind the little-seen Splinter Cell remake.

Ubisoft has apparently laid off yet more employees, and this time, it's the studio's Toronto division that's been hit.

Upheaval at Ubisoft continues today with the departure of veteran creative director Clint Hocking, in the middle of development on the company's next major Assassin's Creed blockbuster.

It has already been a depressingly busy year for layoffs at Ubisoft, and the French publisher’s Toronto studio is the latest workforce to be hit. Around 40 jobs have been cut at the studio, which is ...

Free AI tools Goose and Qwen3-coder may replace a pricey Claude Code plan. Setup is straightforward but requires a powerful local machine. Early tests show promise, though issues remain with accuracy ...

Scientists have developed injectable "mini livers" that can replicate liver function, potentially buying time for those with liver disease.

An insider leaks several new details about Assassin's Creed Hexe, including its alleged release window and the return of a fan-favorite character.

Stem cell therapy biotech PrimeGen US is taking the less-traveled special purpose acquisition company (SPAC) route to the public markets. The California biotech, which is working on preclinical stem ...

Cell Source, Inc. is a biotechnology company, which focuses on developing cell therapy treatments based on the management of immune tolerance. Its Veto Cell immune system management technology is an ...